ROQUEFORT THERAPEUTICS PLC
ROQ | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMDQ2T15
- LEI:
- 254900P4SISIWOR9RH34
- Country:
- United Kingdom
- Address:
- 85 Great Portland Street, W1W 7LT London
- Website:
- https://www.roquefortplc.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Roquefort Therapeutics PLC focuses on developing next-generation cancer treatments using RNA-based therapies and targeted approaches in the UK.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-02 08:00 |
General Meeting Notice
Notice of Annual General Meeting
|
English | 10.3 KB | |
| 2025-05-23 08:00 |
Capital/Financing Update
Extension of Convertible Loan Notes
|
English | 11.9 KB | |
| 2025-05-20 08:50 |
Annual Report (ESEF)
2024 Annual Report
|
English | 1.8 MB | |
| 2025-05-20 08:50 |
Annual Report
2024 Annual Report
|
English | 3.9 MB | |
| 2025-03-14 08:00 |
Regulatory News Service
Private Placing and Conversion of CLNs
|
English | 14.5 KB | |
| 2025-03-10 08:30 |
Regulatory News Service
Board Changes
|
English | 14.4 KB | |
| 2025-03-10 08:00 |
Regulatory News Service
Proposed Sale of Oncogeni Ltd
|
English | 13.5 KB | |
| 2025-03-04 08:00 |
Business and Financial Review
Update on Sale of Lyramid
|
English | 15.0 KB | |
| 2025-02-04 11:58 |
Directors' Dealings
Director/PDMR Shareholding
|
English | 35.8 KB | |
| 2025-02-03 08:00 |
Regulatory News Service
Share Purchase Agreement Signed - Sale of Lyramid
|
English | 21.5 KB | |
| 2025-01-02 08:00 |
Regulatory News Service
Proposed Sale of Midkine Portfolio
|
English | 16.2 KB | |
| 2024-12-04 17:00 |
Directors' Dealings
Director Share Distribution
|
English | 43.8 KB | |
| 2024-11-07 08:00 |
Regulatory News Service
Conversion of Convertible Loan Notes
|
English | 45.5 KB | |
| 2024-11-06 08:00 |
Regulatory News Service
STAT-6 siRNA Presentation
|
English | 16.7 KB | |
| 2024-09-27 08:00 |
Earnings Release
Interim Results to 30 June 2024
|
English | 205.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Vivoryon Therapeutics N.V. | Germany | VVY | |
|
Vytrus Biotech S.A. | Spain | VYT | |
|
WntResearch AB | Sweden | WNT | |
|
Xbrane Biopharma | Sweden | XBRANE | |
|
Xintela AB | Sweden | XINT | |
|
XTL Biopharmaceuticals Ltd. | Israel | XTLB | |
|
Zealand Pharma | Denmark | ZEAL | |
|
Zelluna ASA | Norway | ULTI | |
|
Zephyrus Wing Energies Ltd. | Israel | ZPRS | |
|
Ziccum AB | Sweden | ZICC |